tradingkey.logo

Borealis Foods Inc

BRLS
3.670USD
+0.010+0.27%
Horarios del mercado ETCotizaciones retrasadas 15 min
78.72MCap. mercado
PérdidaP/E TTM

Borealis Foods Inc

3.670
+0.010+0.27%

Más Datos de Borealis Foods Inc Compañía

Borealis Foods, Inc. is a food technology company that addresses global food security challenges through its research and development of nutritious and functional food products. Through its wholly owned subsidiary, Palmetto Gourmet Foods (PGF), the Company has created meals that are organic, vegan, vegetarian, Halal, Kosher, plant-based, egg free and dairy free, non-GMO, free of added monosodium glutamate (MSG) and tert-butylhydroquinone (TBHQ) free. Its initial product line is ramen noodles. Its subsidiary, PGF, uses the Company's technology to make Chef Woo ramen, a plant-based ramen meal on the market. In addition to Chef Woo, PGF also produces a range of other plant-based ramen products, including Ramen Express, its lower-cost premium ramen. Its products are available across several channels of mass merchandiser, club stores, and others. The Company's products are available at approximately 20,000 points of distribution primarily in the United States, Canada, Mexico, and Europe.

Información de Borealis Foods Inc

Símbolo de cotizaciónBRLS
Nombre de la empresaBorealis Foods Inc
Fecha de salida a bolsaOct 06, 2021
Director ejecutivoDr. Reza Soltanzadeh, M.D.
Número de empleados147
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 06
Dirección1540 Cornwall Rd #104
CiudadOAKVILLE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalL6J 7W5
Teléfono19052782200
Sitio Webhttps://www.borealisfoods.com/
Símbolo de cotizaciónBRLS
Fecha de salida a bolsaOct 06, 2021
Director ejecutivoDr. Reza Soltanzadeh, M.D.

Ejecutivos de Borealis Foods Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Reza Soltanzadeh, M.D.
Dr. Reza Soltanzadeh, M.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.66M
--
Mr. Barthelemy Helg
Mr. Barthelemy Helg
Non-Executive Chairman of the Board, Co-Founder
Non-Executive Chairman of the Board, Co-Founder
3.23M
+0.62%
Mr. Matt Talle
Mr. Matt Talle
Chief Strategy Officer
Chief Strategy Officer
214.66K
--
Ms. Pouneh Rahimi
Ms. Pouneh Rahimi
Chief Legal Officer
Chief Legal Officer
192.37K
--
Mr. Shiv Vikram Khemka
Mr. Shiv Vikram Khemka
Independent Director
Independent Director
70.00K
+40.00%
Mr. Stephen Wegrzyn
Mr. Stephen Wegrzyn
Chief Financial Officer
Chief Financial Officer
33.05K
--
Mr. Henry Wong
Mr. Henry Wong
Chief Marketing Officer
Chief Marketing Officer
14.33K
--
Mr. Steven Oyer
Mr. Steven Oyer
Independent Director
Independent Director
--
--
Mr. Shukhrat Ibragimov
Mr. Shukhrat Ibragimov
Director
Director
--
--
Amb. Ertharin Cousin
Amb. Ertharin Cousin
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Reza Soltanzadeh, M.D.
Dr. Reza Soltanzadeh, M.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.66M
--
Mr. Barthelemy Helg
Mr. Barthelemy Helg
Non-Executive Chairman of the Board, Co-Founder
Non-Executive Chairman of the Board, Co-Founder
3.23M
+0.62%
Mr. Matt Talle
Mr. Matt Talle
Chief Strategy Officer
Chief Strategy Officer
214.66K
--
Ms. Pouneh Rahimi
Ms. Pouneh Rahimi
Chief Legal Officer
Chief Legal Officer
192.37K
--
Mr. Shiv Vikram Khemka
Mr. Shiv Vikram Khemka
Independent Director
Independent Director
70.00K
+40.00%
Mr. Stephen Wegrzyn
Mr. Stephen Wegrzyn
Chief Financial Officer
Chief Financial Officer
33.05K
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: jue., 30 de oct
Actualizado: jue., 30 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Oxus Capital Pte Ltd
24.80%
Soltanzadeh (Reza)
17.12%
Helg (Barthelemy)
15.09%
Belphar Ltd
13.32%
GSS Overseas Ltd
1.76%
Otro
27.91%
Accionistas
Accionistas
Proporción
Oxus Capital Pte Ltd
24.80%
Soltanzadeh (Reza)
17.12%
Helg (Barthelemy)
15.09%
Belphar Ltd
13.32%
GSS Overseas Ltd
1.76%
Otro
27.91%
Tipos de accionistas
Accionistas
Proporción
Corporation
39.88%
Individual Investor
36.07%
Investment Advisor/Hedge Fund
0.04%
Otro
24.01%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
27
8.27K
0.04%
-1.89M
2025Q2
42
16.28M
76.13%
-2.00M
2025Q1
42
16.19M
75.72%
+1.45M
2024Q4
78
16.19M
75.71%
-9.56M
2024Q3
82
16.19M
75.72%
-9.68M
2024Q2
87
16.19M
75.71%
-10.67M
2024Q1
91
16.29M
78.38%
-11.59M
2023Q4
85
3.83M
100.30%
-13.73M
2023Q3
83
3.74M
97.59%
-14.42M
2023Q2
82
3.61M
94.30%
-15.02M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Oxus Capital Pte Ltd
5.30M
24.8%
--
--
Apr 15, 2025
Soltanzadeh (Reza)
3.66M
17.12%
--
--
Apr 15, 2025
Helg (Barthelemy)
3.23M
15.09%
+20.00K
+0.62%
May 27, 2025
Belphar Ltd
2.85M
13.32%
--
--
Apr 15, 2025
GSS Overseas Ltd
375.93K
1.76%
--
--
Apr 15, 2025
Mynzhanov (Kanat)
260.00K
1.22%
+10.00K
+4.00%
May 27, 2025
Talle (Matt)
214.66K
1%
--
--
Apr 15, 2025
Rahimi (Pouneh)
192.37K
0.9%
--
--
Apr 15, 2025
Khemka (Shiv Vikram)
70.00K
0.33%
+20.00K
+40.00%
May 27, 2025
Wegrzyn (Stephen)
33.05K
0.15%
--
--
Apr 15, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI